Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

S288T mutation altering MmpL3 periplasmic domain channel and H-bond network: a novel dual drug resistance mechanism.

  • Authors : Ge Y; Department of Thoracic Oncology, Affiliated Cancer Hospital, Guizhou Medical University, Guiyang, China.; Key Laboratory of Medicinal and Edible Plants Resources Development of Sichuan Education Department, School of Pharmacy, Chengdu University, Chengdu, 610106, China.

Subjects: Protons* ; Mycobacterium tuberculosis*/Mycobacterium tuberculosis*/Mycobacterium tuberculosis*/genetics ; Ethylenediamines*

  • Source: Journal of molecular modeling [J Mol Model] 2024 Jan 15; Vol. 30 (2), pp. 39. Date of Electronic Publication: 2024 Jan 15.Publisher: Springer Country of Publication: Germany NLM ID: 9806569 Publication Model: Electronic Cited Medium: Internet ISSN: 0948-5023

Record details

×
Academic Journal

Discovery of 2,9-diaryl-6-carbamoylpurines as a novel class of antitubercular agents.

  • Authors : Correia C; CQUM - Centre of Chemistry, Department of Chemistry, University of Minho, Campus de Gualtar, 4710-057, Braga, Portugal.; Leite AC

Subjects: Mycobacterium tuberculosis* ; Tuberculosis*/Tuberculosis*/Tuberculosis*/drug therapy ; Tuberculosis*/Tuberculosis*/Tuberculosis*/microbiology

  • Source: European journal of medicinal chemistry [Eur J Med Chem] 2024 Mar 15; Vol. 268, pp. 116297. Date of Electronic Publication: 2024 Mar 02.Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 0420510 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

The diagnosis of central nervous system infections in resource-limited settings and the use of novel and molecular diagnostic platforms to improve diagnosis.

  • Authors : Milburn J; Botswana Harvard AIDS Institute Partnership, Gaborone, Botswana.; Department of Clinical Research, Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK.

Subjects: Mycobacterium tuberculosis*/Mycobacterium tuberculosis*/Mycobacterium tuberculosis*/genetics; Humans ; Pathology, Molecular

  • Source: Expert review of molecular diagnostics [Expert Rev Mol Diagn] 2024 Mar; Vol. 24 (3), pp. 219-230. Date of Electronic Publication: 2024 Feb 19.Publisher: Taylor & Francis Country of Publication: England NLM ID: 101120777 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

A novel synergistic enzyme-antibiotic therapy with immobilization of mycobacteriophage Lysin B enzyme onto Rif@UiO-66 nanocomposite for enhanced inhaled anti-TB therapy; Nanoenzybiotics approach.

  • Authors : Eldin ZE; Materials Science and Nanotechnology Department, Faculty of Postgraduate Studies for Advanced Sciences, Beni-Suef University, 62511 Beni-Suef, Egypt. Electronic address: .; Dishisha T

Subjects: Mycobacteriophages* ; Tuberculosis*/Tuberculosis*/Tuberculosis*/drug therapy ; Mycobacterium tuberculosis*

  • Source: International journal of biological macromolecules [Int J Biol Macromol] 2024 Mar; Vol. 262 (Pt 1), pp. 129675. Date of Electronic Publication: 2024 Jan 26.Publisher: Elsevier Country of Publication: Netherlands NLM ID: 7909578 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Targeting of essential mycobacterial replication enzyme DnaG primase revealed Mitoxantrone and Vapreotide as novel mycobacterial growth inhibitors.

  • Authors : Ali W; Jamia Hamdard, Department of Molecular Medicine, New Delhi, 110062, India.; Jamal S

Subjects: Mycobacterium tuberculosis*; Somatostatin/Somatostatin/Somatostatin/*analogs & derivatives; Humans

  • Source: Molecular informatics [Mol Inform] 2024 Mar; Vol. 43 (3), pp. e202300284. Date of Electronic Publication: 2024 Feb 06.Publisher: Wiley-VCH Verlag Country of Publication: Germany NLM ID: 101529315 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Novel mutation in efflux pump Rv1258c (Tap) gene in drug resistant clinical isolates of Mycobacterium tuberculosis in Iran.

  • Authors : Farzaneh S; Department of Microbiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.; Norouzi F

Subjects: Mycobacterium tuberculosis*/Mycobacterium tuberculosis*/Mycobacterium tuberculosis*/genetics ; Tuberculosis, Multidrug-Resistant*; Humans

  • Source: Journal of infection in developing countries [J Infect Dev Ctries] 2024 Feb 29; Vol. 18 (2), pp. 243-250. Date of Electronic Publication: 2024 Feb 29.Publisher: Open Learning on Enteric Pathogens Country of Publication: Italy NLM ID: 101305410 Publication Model: Electronic Cited Medium: Internet

Record details

×
Academic Journal

Discovery of N -(1-(6-Oxo-1,6-dihydropyrimidine)-pyrazole) Acetamide Derivatives as Novel Noncovalent DprE1 Inhibitors against Mycobacterium tuberculosis .

  • Authors : Yang L; College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China.; Hu X

Subjects: Mycobacterium tuberculosis*; Humans ; Antitubercular Agents/Antitubercular Agents/Antitubercular Agents/pharmacology

  • Source: Journal of medicinal chemistry [J Med Chem] 2024 Feb 08; Vol. 67 (3), pp. 1914-1931. Date of Electronic Publication: 2024 Jan 17.Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print-Electronic Cited Medium: Internet

Record details

×
Academic Journal

The heme oxygenase-1 metalloporphyrin inhibitor stannsoporfin enhances the bactericidal activity of a novel regimen for multidrug-resistant tuberculosis in a murine model.

  • Authors : Ruelas Castillo J; Center for Tuberculosis Research, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.; Neupane P

Subjects: Metalloporphyrins*/Metalloporphyrins*/Metalloporphyrins*/therapeutic use ; Tuberculosis, Multidrug-Resistant*/Tuberculosis, Multidrug-Resistant*/Tuberculosis, Multidrug-Resistant*/drug therapy ; Mycobacterium tuberculosis*

  • Source: Antimicrobial agents and chemotherapy [Antimicrob Agents Chemother] 2024 Feb 07; Vol. 68 (2), pp. e0104323. Date of Electronic Publication: 2023 Dec 22.Publisher: American Society for Microbiology Country of Publication: United States NLM ID: 0315061 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

A novel diagnostic model for tuberculous meningitis using Bayesian latent class analysis.

  • Authors : Dong THK; Centre for Tropical Medicine, Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam. .; King's College London, London, UK. .

Subjects: Tuberculosis, Meningeal*/Tuberculosis, Meningeal*/Tuberculosis, Meningeal*/diagnosis ; Mycobacterium tuberculosis* ; HIV Infections*

  • Source: BMC infectious diseases [BMC Infect Dis] 2024 Feb 06; Vol. 24 (1), pp. 163. Date of Electronic Publication: 2024 Feb 06.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334

Record details

×
Academic Journal

A novel Mycobacterium Tuberculosis antigen, MTB48 enhances inflammatory response in LPS-induced RAW264.7 macrophage immune cells.

  • Authors : Park JY; Department of Biological Science, SungKyunkwan University, Suwon 16419, Republic of Korea; Environmental Diseases Research Center, Korea Research Institute of Bioscience and Biotechnology, Daejeon, South Korea.

Subjects: Tuberculosis* ; Mycobacterium tuberculosis* ; Antigens, Bacterial*

  • Source: Molecular immunology [Mol Immunol] 2024 Feb; Vol. 166, pp. 50-57. Date of Electronic Publication: 2024 Jan 17.Publisher: Pergamon Press Country of Publication: England NLM ID: 7905289 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  19,408 results for ""Novel""